Cargando…
Increase in activity of Na(+), K(+)-ATPase by Porphyrin compounds as treatment for Dysnatremias caused by Diabetes Mellitus
OBJECTIVE: The aim of this study was to test the action of Porphyrin compounds, Tetraphenylporphine sulfonate (TPPS), 5,10,15,20-Tetrakis (4-sulfonatophenyl) porphyrinato Iron(III) Chloride (FeTPPS) and 5,10,15,20-Tetrakis (4-sulfonatophenyl) porphyrinato Iron(III) nitrosyl Chloride (FeNOTPPS), on N...
Autores principales: | Hai, Abdul, Kizilbash, Nadeem |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Professional Medical Publications
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5103120/ https://www.ncbi.nlm.nih.gov/pubmed/27882008 http://dx.doi.org/10.12669/pjms.325.11530 |
Ejemplares similares
-
Binding interactions of porphyrin derivatives with Ca(2+) ATPase of sarcoplasmic reticulum (SERCA1a)
por: Hai, Abdul, et al.
Publicado: (2013) -
Porphyrin derivatives as inhibitors for acetylcholinesterase from Drosophila melanogaster
por: Hai, Abdul, et al.
Publicado: (2013) -
Understanding dysnatremia
por: Voets, Philip J. G. M., et al.
Publicado: (2020) -
Dysnatremia in Gastrointestinal Disorders
por: Do, Catherine, et al.
Publicado: (2022) -
C-peptide, Na(+),K(+)-ATPase, and Diabetes
por: Vague, P., et al.
Publicado: (2004)